Skip to content
State Street SPDR S&P Biotech ETF

State Street SPDR S&P Biotech ETF technical analysis

XBIHealth Updated daily

Technical analysis of State Street SPDR S&P Biotech ETF (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is State Street SPDR S&P Biotech ETF

The State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that tracks the performance of the S&P Biotechnology Select Industry Index through a sampling strategy. The fund invests at least 80% of its assets in the securities comprising the index, which represents the biotechnology segment of the S&P Total Market Index.

Description generated automatically from public sources; it may be inaccurate or out of date.

State Street SPDR S&P Biotech ETF: latest session data

Closing values for October 21, 2026, computed on the last 12 months of prices.

Close153.37 $
Change+0.08%
RSI (14)50.5
MACD-2.033
ADX16.5
Volatility (ATR)2.87%
Volume vs 20-avg48%
12-month high169.89 $
12-month low124.95 $

Moving averages

21 sessions

152.39 $

+0.64%

50 sessions

157.58 $

−2.67%

200 sessions

140.54 $

+9.13%

Session levels

s2

145.45

Support

s1

149.34

Support

pivot

151.66

Pivot

r1

155.55

Resistance

r2

157.87

Resistance

How to read it

In the October 21, 2026 session State Street SPDR S&P Biotech ETF closed higher at 153.37 $, +0.08% versus the previous session.

The price sits mixed against its moving averages: +0.64% against the 21-session average, −2.67% against the 50 and +9.13% against the 200.

The 14-period RSI reads 50.5, in neutral territory.

MACD stands at -2.033 against a signal line at -2.310: the histogram is positive (+0.277).

ADX reads 16.5, indicating weak directionality.

Levels computed on the latest session place supports at 149.34 and 145.45 $ and resistances at 155.55 and 157.87 $, around a pivot of 151.66.

The average daily range (ATR) is 4.396 $, or 2.87% of price.

Turnover was 4.7M shares, 48% of the 20-session average.

Over the last twelve months the price ranged between 124.95 and 169.89 $, and today stands −9.72% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of State Street SPDR S&P Biotech ETF

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the XBI analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about State Street SPDR S&P Biotech ETF

How is State Street SPDR S&P Biotech ETF analysed technically?

Technical analysis of State Street SPDR S&P Biotech ETF is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for State Street SPDR S&P Biotech ETF?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to State Street SPDR S&P Biotech ETF?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to State Street SPDR S&P Biotech ETF it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.